Clinics in Dermatology
Volume 28, Issue 5 , Pages 519-526 , September 2010

Chronic wound infection: Facts and controversies

  • Abdul R. Siddiqui, MD

      Affiliations

    • Medical Service, Department of Veterans Affairs Medical Center, Dayton, OH 45428, USA
    • Division of Infectious Diseases, Department of Medicine, Wright State University Boonshoft School of Medicine, Dayton, OH 45435, USA
    • ,
  • Jack M. Bernstein, MD

      Affiliations

    • Medical Service, Department of Veterans Affairs Medical Center, Dayton, OH 45428, USA
    • Division of Infectious Diseases, Department of Medicine, Wright State University Boonshoft School of Medicine, Dayton, OH 45435, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 937 262 3393.

References 

  1. Gottrup F. A specialized wound-healing center concept: importance of a multidisciplinary department structure and surgical treatment facilities in the treatment of chronic wounds. Am J Surg. 2004;187:38S–43S
  2. Mustoe T. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg. 2004;187(5 Suppl 1):S65–S70
  3. Kruse I, Edelman S. Evaluation and treatment of diabetic foot ulcers. Clin Diabet. 2006;24:91–93
  4. Barone EJ, Yager DR, Pozez AL, et al. Interleukin-1 alpha and collagenase activity are elevated in chronic wounds. Plast Reconstr Surg. 1998;102:1023–1027
  5. Walmsley S. Advances in wound management: executive summary. Clinica Reports London: PJB Publications, Ltd.; 2002;
  6. Fowler E. Chronic wounds: an overview. In:  Krasner D editors. Chronic wound care: a clinical source book for healthcare professionals. King of Prussia, PA: Health Management Publications Inc; 1990;p. 12–18
  7. Singh A, Halder S, Menon GR, et al. Meta-analysis of randomized controlled trials on hydrocolloid occlusive dressing versus conventional gauze dressing in the healing of chronic wounds. Asian J Surg. 2004;27:326–332
  8. Brunicardi F. Charles Schwartz's principles of surgery. 8th ed.. New York: McGraw-Hill; 2004;
  9. Frank C, Bayoumi I, Westendorp C. Approach to infected skin ulcers. Can Fam Physician. 2005;51:1352–1359
  10. Kingsley A. The wound infection continuum and its application to clinical practice. Ostomy Wound Manage. 2003;49:S1–S7
  11. Laato M, Niinikoski J, Lundberg C, et al. Inflammatory reaction and blood flow in experimental wounds inoculated with Staphylococcus aureus. Eur Surg Res. 1988;20:33–38
  12. Ovington L. Bacterial toxins and wound healing. Ostomy Wound Manage. 2003;49(7 Suppl A):8–12
  13. Cutting KF, White RJ. Criteria for identifying wound infection—revisited. Ostomy Wound Manage. 2005;51:28–34
  14. Salcido R. What is bioburden? The link to chronic wounds. Adv Skin Wound Care. 2007;20:368
  15. Wysocki AB. Evaluating and managing open skin wounds: colonization versus infection. AACN Clin Issues. 2002;13:382–397
  16. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev. 2001;14:244–269
  17. Hansson C, Hoborn J, Moller A, et al. The microbial flora in venous leg ulcers without clinical signs of infection. Acta Dermato Venereol. 1995;75:24–30
  18. Gjodsbol K, Christensen J, Karlsmark T, et al. Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J. 2006;3:225–231
  19. Bowler PG, Davies BJ. The microbiology of acute and chronic wounds. Wounds. 1999;11:72–78
  20. Sheffield PJ. Tissue Oxygen Measurements. In:  Jefferson CD,  Hunt TK editor. Problem Wounds: The Role of Oxygen. Amsterdam: Elsevier; 1988;p. 17–51
  21. Landis SJ. Chronic wound infection and antimicrobial use. Adv Skin Wound Care. 2008;21:531–540
  22. Howell-Jones RS, Wilson MJ, Hill KE, et al. A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother. 2005;55:143–149
  23. Gerding DN. Foot infections in diabetic patients: the role of anaerobes. Clin Infect Dis. 1995;20(Suppl 2):S283–S288
  24. Hartemann-Heurtier A, Robert J, Jacqueminent S, et al. Diabetic foot ulcer and multidrug resistant organisms: risk factors and impact. Diabet Med. 2004;21:710–715
  25. Trengove N, Stacey M, McGechie D, et al. Qualitative bacteriology and leg ulcer healing. J Wound Care. 1996;5:277–280
  26. Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov. 2003;2:114–122
  27. Kievit TR, Iglewski BH. Bacterial quorum sensing in pathogenic relationships. Infect Immun. 2000;68:4839–4849
  28. Wolcott R.D., Rhoads D.D. A study of biofilm-based wound management in subjects with critical limb ischaemia. J Wound Care 1996;17:145-142, 154.
  29. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167–193
  30. Donlan RM. Biofilm formation: A clinically relevant microbiological process. Clin Infect Dis. 2001;33:1387–1392
  31. In:  Mandell GL,  Bennett JE,  Dolin R editor. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Elsevier; 2005;p. 21–22
  32. Davis SC, Martinez L, Kirsner R. The diabetic foot: the importance of biofilms and wound bed preparation. Curr Diabet Rep. 2006;6:439–445
  33. Hurlow J, Bowler PG. Clinical experience with wound biofilm and management: a case series. Ostomy Wound Manage. 2009;55:38–49
  34. Bamberg R, Sullivan PK, Conner-Kerr TA. Diagnosis of wound infections: current culturing practices of US wound care professionals. Wounds. 2002;14:314–327
  35. Cutting KF, Harding KG. Criteria for identifying wound infection. J Wound Care. 1994;3:198–201
  36. Serena TE, Robson MC, Cooper DM, et al. Lack of reliability of clinical/visual assessment of chronic wound infection: the incidence of biopsy-proven infection in venous leg ulcers. Wounds. 2006;18:197–202
  37. American Diabetes Association . Consensus development conference on diabetic foot wound care. Diabet Care. 1999;22:1354–1360
  38. Douglas WS, Simpson NB. Guidelines for the management of chronic venous leg ulceration. Report of a multidisciplinary workshop. Br J Dermatol. 1995;132:446–452
  39. Sibbald RG, Woo K, Ayello EA. Increased bacterial burden and infection: the story of NERDS and STONEES. Adv Skin Wound Care. 2006;19:447–463
  40. Woo KY, Sibbald RG. A cross-sectional validation study of using NERDS and STONEES to assess bacterial burden. Ostomy Wound Manage. 2009;55:40–48
  41. Robson M, Heggers J. Bacterial quantification of open wounds. Mil Med. 1969;134:19–24
  42. Robson M. Wound infection: a failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am. 1997;77:637–650
  43. Bergstrom N, Allman R, Alvarez O, et al. Clinical practice guideline number 15: treatment of pressure ulcers. AHCPR Publication 95-0652. Public Health Service. Agency for Health Care Policy and Research. Rockville, MD: US Department of Health Human Services; 1994;
  44. Gardner SE, Frantz RA. Wound bioburden. In:  Baranoski S,  Ayello EA editor. Wound care essentials practice principles. New York, NY: Lippincott, Williams & Wilkins; 2004;p. 91–116
  45. Ratliff CR, Rodeheaver GT. Correlation of semi-quantitative swab cultures to quantitative swab cultures from chronic wounds. Wounds. 2002;14:329–333
  46. Gardner SE, Frantz RA, Hillis SL, Park H, Scherubel M. Diagnostic validity of semiquantitative swab cultures. Wounds. 2007;19:31–38
  47. Sapico F, Ginunas V, Thornhill-Joynes M, et al. Quantitative microbiology of pressure sores in different stages of healing. Diagn Microbiol Infect Dis. 1986;5:31–38
  48. Fleck C. Identifying infection in chronic wounds. Adv Skin Wound Care. 2006;19:20–21
  49. Healy B, Freedman A. ABC of wound healing: infections. BMJ. 2006;332:838–841
  50. Perry C, Pearson R, Miller G. Accuracy of cultures of material from swabbing of the superficial aspect of the wound and needle biopsy in the preoperative assessment of osteomyelitis. J Bone Joint Surg Am. 1991;73:745–749
  51. Dow G. Bacterial swabs and the chronic wound: when, how, and what do they mean?. Ostomy Wound Manage. 2003;49(5A Suppl):8–13
  52. Gilchrist B. Taking a wound swab. Nurs Times. 2000;96(Suppl 4):2
  53. Cooper R, Lawrence J. The isolation and identification of bacteria from wounds. J Wound Care. 1996;5:335–340
  54. Sapico F, Witte J, Canawati H, et al. The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features. Rev Infect Dis. 1984;6(Supp 1):S171–S176
  55. Bonham PA. Swab cultures for diagnosing wound infections. a literature review and clinical guideline. J Wound Ostomy Continence Nurs. 2009;36:389–395
  56. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12:147–179
  57. Wilson JR, Mills JG, Prather ID, et al. A toxicity index of skin and wound cleansers used on in vitro fibroblasts and keratinocytes. Adv Skin Wound Care. 2005;18:373–378
  58. Cooper R. A review of the evidence for the use of topical antimicrobial agents in wound care. World Wide Wounds. www.worldwidewounds.com/2004/february/Cooper/Topical-Antimicrobia
  59. Ebright JR. Microbiology of chronic leg and pressure ulcers: clinical significance and implications for treatment. Nurs Clin North Am. 2005;40:207–216
  60. Eron LJ, Lipsky BA, Low DE, et al. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother. 2003;52(Suppl 1):i3–i17
  61. Local applications to wounds: 1. Cleansers, antibacterials, debriders. Drug Therapeut Bull. 1991;29:93–95
  62. Zaki I, Shall L, Dalziel KL. Bacitracin: a significant sensitizer in leg ulcer patients?. Contact Dermatitis. 1994;31:92–94
  63. Darsow U. The European Task Force on Atopic Dermatitis. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol. 2005;19:286–295
  64. Editorial. BMJ. 1977;1:494
  65. Alinovi A, Bassissi P, Pini M. Systemic administration of antibiotics in the management of venous ulcers. J Am Acad Dermatol. 1986;15:186–191
  66. Huovinen S, Kotilainen P, Jarvinen H, et al. Comparison of ciprofloxacin or trimethoprim therapy for venous leg ulcers: results of a pilot study. J Am Acad Dermatol. 1994;31:279–281
  67. Fraki JE, Peltonen L, Hopsu-Havu VK. Allergy to various components of topical preparations in stasis dermatitis and leg ulcer. Contact Dermatitis. 1979;5:97–100
  68. The International Working Group on the Diabetic Foot. The International Consensus on the Diabetic Foot. Amsterdam, Netherlands: The International Working Group on the Diabetic Foot; 1999;
  69. National Institute for Clinical Excellence . Type 2 diabetes. Prevention and management of foot problems. Clinical Guideline 10. London, UK: National Institute for Clinical Excellence; 2004;
  70. Scottish Intercollegiate Guidelines Network (SIGN) . The care of patients with chronic leg ulcer. A national clinical guideline. No. 26. Edinburgh, UK: SIGN Publication; 1998;
  71. Tammelin A, Lindholm C, Hambraeus A. Chronic ulcers and antibiotic treatment. J Wound Care. 1998;7:435–437
  72. Centers for Disease Control and Prevention . Staphylococcus aureus resistant to vancomycin—United States. Morbid Mortal Wkly Rep. 2002;51:565–567
  73. Centers for Disease Control and Prevention . Public health dispatch: vancomycin-resistant Staphylococcus aureus—Pennsylvania. Morbid Mortal Wkly Rep. 2002;51:902
  74. Colsky AS, Kirsner RS, Kerdel FA. Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients. The crisis of antibiotic resistance has come to the surface. Arch Dermatol. 1998;134:L1006–1009
  75. Valtonen V, Karppinen L, Kariniemi AL. A comparative study of ciprofloxacin and conventional therapy in the treatment of patients with chronic lower leg ulcers infected with Pseudomonas aeruginosa or other gram-negative rods. Scand J Infect Dis Suppl. 1989;60:79–83
  76. O'Meara S, Al-Kurdi D, Ovington LG. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev. 2008;CD003557
  77. Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004;39:885–910
  78. Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Reg. 2003;11:S1–S28
  79. Grayson ML, Gibbons GW, Balogh K, et al. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA. 1995;273:721–723
  80. Lipsky BA, Pecoraro RE, Larson SA. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med. 1990;150:790–797
  81. Romanelli M, Magliaro A, Mastronicola D, et al. Systemic antimicrobial therapies for pressure ulcers. Ostomy Wound Manage. 2003;49(5A Suppl):25–29

PII: S0738-081X(10)00033-7

doi: 10.1016/j.clindermatol.2010.03.009

Clinics in Dermatology
Volume 28, Issue 5 , Pages 519-526 , September 2010

Article Tools